Publications by authors named "Reem Abdullah Al Khalifah"
Article Synopsis
- - The study aimed to investigate how changing light-dark cycles and consuming soft drinks affect the early development of type 1 diabetes mellitus (T1DM) in non-obese diabetic (NOD) mice.
- - Female NOD mice were tested from 5 weeks old, and adjustments were made to their light cycles and diets until they either developed diabetes or reached 30 weeks old.
- - Results showed that NOD mice with altered light cycles developed T1DM approximately two weeks earlier than control mice, but this finding wasn't statistically significant, indicating a need for more research with larger groups.
Objectives: FreeStyle Libre 1 (FGM) has been approved by the FDA for children older than 4 years. It enables noninvasive glucose monitoring without the need for finger pricking. Parents of very young children often use the device off-label.
View Article and Find Full Text PDFObjectives: We aimed to report our 10-year experience of treating short children born small for gestational age (SGA) by comparing the long-term growth, metabolic safety, and cost-effectiveness of recombinant human growth hormone (rhGH) therapy in short children born SGA with those in rhGH-treated children with growth hormone deficiency (GHD) and Turner syndrome.
Methods: We performed a 10-year retrospective cohort study at King Saud University Medical City. We included children aged 3-16 years who received rhGH for GHD, SGA, or Turner syndrome for >1 year.
Importance: Intravenous (IV) insulin infusion is the standard of care for treating diabetic ketoacidosis (DKA) worldwide. Subcutaneous (SC) insulin aspart could decrease the use of health care resources.
Objective: To compare the cost-effectiveness of mild uncomplicated DKA management with SC insulin aspart vs IV insulin infusion among pediatric patients from the perspective of a public health care payer using clinical data.
Background: There are few Arabic language functional scales for patients with dementia. The Bristol Activity of Daily Living Scale (BADLS) was designed and validated for use in patients with dementia.
Objective: Our study aimed to translate, cross-culturally adapt, and validate the BADLS to the Arabic language for people with neurocognitive decline and dementia.
Aim: We aimed to identify gaps in school care and support required for students with type 1 diabetes mellitus (T1DM) in Saudi Arabia.
Methods: We performed a cross-sectional nationwide study using self-administered surveys that targeted teachers and parents of students with T1DM in Saudi Arabia from August to December 2019.
Results: We collected surveys from 632 parents and 983 teachers.